India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...
Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious ...
India’s air quality challenge is no longer a seasonal concern. It is a persistent public health issue that touches families, cities and insurers alike. As claim ...
GRI Bio (GRI) announced topline data from the Phase 2a GRI-0621-IPF-02 clinical trial evaluating GRI-0621 for the treatment of Idiopathic ...
Winter brings a sharp rise in bronchitis as cold air, pollution, and seasonal viruses inflame the bronchial tubes. Early testing helps prevent serious long-term lung damage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results